Beta Drugs バランスシートの健全性
財務の健全性 基準チェック /66
Beta Drugsの総株主資本は₹1.8B 、総負債は₹190.6Mで、負債比率は10.5%となります。総資産と総負債はそれぞれ₹2.9Bと₹1.1Bです。 Beta Drugsの EBIT は₹558.1Mで、利息カバレッジ比率27.2です。現金および短期投資は₹278.9Mです。
主要情報
10.5%
負債資本比率
₹190.60m
負債
インタレスト・カバレッジ・レシオ | 27.2x |
現金 | ₹278.87m |
エクイティ | ₹1.81b |
負債合計 | ₹1.14b |
総資産 | ₹2.95b |
財務の健全性に関する最新情報
These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well
Jul 29Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly
Dec 20These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well
Sep 02Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly
May 20Is Beta Drugs (NSE:BETA) A Risky Investment?
Jan 29Recent updates
Why Investors Shouldn't Be Surprised By Beta Drugs Limited's (NSE:BETA) 30% Share Price Surge
Nov 08Does Beta Drugs (NSE:BETA) Deserve A Spot On Your Watchlist?
Aug 30Investors Appear Satisfied With Beta Drugs Limited's (NSE:BETA) Prospects As Shares Rocket 27%
Aug 30Earnings Tell The Story For Beta Drugs Limited (NSE:BETA) As Its Stock Soars 29%
Dec 23Does Beta Drugs (NSE:BETA) Deserve A Spot On Your Watchlist?
Dec 11These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well
Jul 29Here's Why We Think Beta Drugs (NSE:BETA) Is Well Worth Watching
Jun 17Here's Why I Think Beta Drugs (NSE:BETA) Might Deserve Your Attention Today
Feb 21Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly
Dec 20With EPS Growth And More, Beta Drugs (NSE:BETA) Is Interesting
Nov 21These 4 Measures Indicate That Beta Drugs (NSE:BETA) Is Using Debt Reasonably Well
Sep 02Beta Drugs (NSE:BETA) Seems To Use Debt Quite Sensibly
May 20Is Beta Drugs (NSE:BETA) A Risky Investment?
Jan 29Is Beta Drugs Limited's (NSE:BETA) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Dec 25Chairman & MD Vijay Batra Just Bought A Handful Of Shares In Beta Drugs Limited (NSE:BETA)
Nov 20財務状況分析
短期負債: BETAの 短期資産 ( ₹2.1B ) が 短期負債 ( ₹972.5M ) を超えています。
長期負債: BETAの短期資産 ( ₹2.1B ) が 長期負債 ( ₹164.0M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: BETA総負債よりも多くの現金を保有しています。
負債の削減: BETAの負債対資本比率は、過去 5 年間で32.5%から10.5%に減少しました。
債務返済能力: BETAの負債は 営業キャッシュフロー によって 十分にカバー されています ( 132.1% )。
インタレストカバレッジ: BETAの負債に対する 利息支払い は EBIT ( 27.2 x coverage) によって 十分にカバーされています。